Efc (i) Rights Issue 2026 vs Indrayani Biotech Rights Issue 2026

Comparison between Efc (i) Rights Issue 2026 and Indrayani Biotech Rights Issue 2026.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Efc (i) Rights Issue 2026 and Indrayani Biotech Rights Issue 2026. Efc (i) Rights Issue 2026 is listed on BSE, NSE while Indrayani Biotech Rights Issue 2026 is listed on BSE.

 Efc (i) LtdIndrayani Biotech Ltd
LogoEfc (i) Rights Issue 2026 LogoIndrayani Biotech Rights Issue 2026 Logo
Listing AtBSE, NSEBSE
Terms of PaymentFull Amount on ApplicationPartial - ₹3.75 on Application
Entitlement8 Rights Equity Share(s) for every 103 fully paid-up Equity Shares held on Record Date5 Rights Equity Share(s) for every 7 fully paid-up Equity Shares held on Record Date
Application FormApplication Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Efc (i) Rights Issue 2026 rights issue is ₹159.94 Crores, whereas Indrayani Biotech Rights Issue 2026 rights issue size is ₹48.79 Crores.

 Efc (i) LtdIndrayani Biotech Ltd
Issue Size1,06,62,786 shares3,25,25,897 shares
Issue Size (Amount)₹159.94 Crores₹48.79 Crores
Issue Price₹150 per share₹15 per share
Face Value₹2 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Efc (i) Rights Issue 2026 is May 07, 2026 while record date of Indrayani Biotech Rights Issue 2026 is Apr 28, 2026.

 Efc (i) LtdIndrayani Biotech Ltd
Record DateMay 07, 2026Apr 28, 2026
Credit of Rights EntitlementsMay 08, 2026
Bid/Offer Opens OnMay 13, 2026Jun 25, 2026
Renunciation of Rights EntitlementsMay 18, 2026Jul 20, 2026
Bid/Offer Closes OnMay 22, 2026Jul 24, 2026
Deemed Date of AllotmentMay 25, 3036
Credit DateMay 26, 2026
Listing DateMay 27, 2026

Financials details

Comparison of Efc (i) Rights Issue 2026 and Indrayani Biotech Rights Issue 2026 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Efc (i) LtdIndrayani Biotech Ltd
Financial

Company Financials (Restated Consolidated)

Period Ended31 Dec 202531 Mar 202531 Mar 0024
Assets1,699.17980.34
Total Income743.80656.74419.46
Profit After Tax165.80140.7763.30
EBITDA345.20191.92
NET Worth737.30579.42426.83
Reserves and Surplus709.84559.51416.87
Total Borrowing1.921.01
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Mar 202431 Mar 2023
Assets235.03155.96
Total Income167.44167.41
Profit After Tax10.4211.93
Amount in ₹ Crore

Compare with others

Compare:

Efc (i) Rights Issue 2026 Vs Indrayani Biotech Rights Issue 2026